Key result
A modified cardiac rehabilitation program with early clinical pharmacy services significantly improved the physical component summary of quality of life in patients with acute coronary syndrome.
Why the study?
Does early phase I pharmaceutical care intervention in a modified cardiac rehabilitation program improve quality of life in patients newly diagnosed with acute coronary syndrome?
Population
112 patients newly diagnosed with acute coronary syndrome (ACS) treated at a referral hospital in Malaysia
Comparison
Modified Cardiac Rehabilitation Programme… vs Conventional Cardiac Rehabilitation Programme…
Design
Cohort
Follow-up
12 months
Authors
Loading...
May support pharmacist integration in early ACS rehab; hypothesis-generating and needs RCT confirmation before practice change.
Cohort (n=112)
Open-label
None
No
Does early phase I pharmaceutical care intervention in a modified cardiac rehabilitation program improve quality of life in patients newly diagnosed with acute coronary syndrome?
Mean Difference: 11.46 (95% CI 3.46–18.85)
Absolute Event Rate: 11.46% vs 6.41%
p-value: p=0.008
Early pharmaceutical care intervention by clinical pharmacists during phase I cardiac rehabilitation significantly improves long-term physical and social quality of life in patients with acute coronary syndrome.
Anchah et al. (2017) conducted a cohort in Acute Coronary Syndrome (n=112). Modified Cardiac Rehabilitation Programme (MCRP) with early clinical pharmacy services vs. Conventional CRP and usual care (control) was evaluated on Physical component summary (PCS) score change from baseline at 12 months (MD 11.46, 95% CI 3.46-18.85, p=0.008). A modified cardiac rehabilitation program with early clinical pharmacy services significantly improved the physical component summary of quality of life in patients with acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: